| ADMET | Absorption, distribution, metabolism, and excretion properties and toxicities which are useful in evaluating pharmecuetical properties of prospective therapeutics. |
| Antibacterial | A compound that kills bacteria or prevents bacterial growth. |
| BDC50 | The concentration at which 50% of the preformed biofilm is dispersed. |
| BIC50 | The concentration at which 50% of biofilm formation is inhibited. |
| Biofilm inhibitor | A compound that inhibits or negatively impacts biofilm formation. This includes the prevention of biofilm formation as well as dispersal and disruption of preformed biofilms. |
| DGC | Diguanylate cyclase |
| EC50 | The concentration at which treatment is 50% effective. |
| EDC condition | 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) is used as a carboxyl activating agent to form amide bonds in coupling reactions. |
| IC50 | The concentration at which enzymatic activity is 50% inhibited. |
| MBEC | Minimal biofilm eradication concentration. |
| MIC | Minimal inhibitory concentration. |
| MoTr | Cell associated or cell-penetrating molecular transporter. |
| PDE | Phosphodiesterase |
| QS | Quorum sensing |